Literature DB >> 10716479

Observed and relative survival after aortic valve replacement.

P Kvidal1, R Bergström, L G Hörte, E Ståhle.   

Abstract

OBJECTIVES: We sought to evaluate the effects of a number of factors that can potentially determine the optimal time for aortic valve replacement (AVR) and the observed and relative survival after the operation.
BACKGROUND: Aortic valve replacement is performed in patients within a wide age span, but the proportion of elderly patients is increasing. In survival analyses, adjustment for the effects of age is therefore essential. Analysis of relative survival provides additional information on excess or disease-specific mortality and its risk factors.
METHODS: Survival was analyzed in 2,359 patients (1,442 without and 917 with concomitant coronary artery bypass graft surgery) undergoing their first AVR. By relating observed survival to that expected among the general Swedish population stratified by age, gender and five-year calendar period, the relative survival and disease-specific survival were estimated.
RESULTS: Early mortality after AVR (death within 30 days) was 5.6%. Relative survival rates (excluding early deaths) after 5, 10 and 15 years were 94.6%, 84.7% and 74.9%, respectively. There was an excess risk of dying during the entire follow-up period. Advanced New York Heart Association functional class, preoperative atrial fibrillation and pure aortic regurgitation were independent risk factors for observed and relative survival. Patients in the oldest age group showed decreased observed survival but excellent relative survival.
CONCLUSIONS: Old age was not a risk factor for excess mortality after AVR, whereas atrial fibrillation decreased relative survival substantially.

Entities:  

Mesh:

Year:  2000        PMID: 10716479     DOI: 10.1016/s0735-1097(99)00584-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  81 in total

Review 1.  Interface between valve disease and ischaemic heart disease.

Authors:  B Iung
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

2.  Current status of percutaneous valvular procedures.

Authors:  Dominique Himbert; Eric Brochet; David Messika-Zeitoun; Alec Vahanian
Journal:  Curr Treat Options Cardiovasc Med       Date:  2006-11

3.  51-year-old man with heart murmur.

Authors:  Tanya H Tajouri; Gautam Kumar; Kyle W Klarich
Journal:  Mayo Clin Proc       Date:  2010-11       Impact factor: 7.616

4.  Aortic stenosis: An update.

Authors:  Sangeetha Nathaniel; Shreyas Saligram; Antony Leslie Innasimuthu
Journal:  World J Cardiol       Date:  2010-06-26

Review 5.  Pre-procedural risk models for patients undergoing transcatheter aortic valve implantation.

Authors:  Glen P Martin; Matthew Sperrin; Mamas A Mamas
Journal:  J Thorac Dis       Date:  2018-11       Impact factor: 2.895

6.  Geographically Derived Socioeconomic Factors to Improve Risk Prediction in Patients Having Aortic Valve Replacement.

Authors:  Fenton H McCarthy; Lingjiao Zhang; Vicky Tam; Jinbo Chen; Chase Brown; William L Patrick; Walter Clark Hargrove; Wilson Y Szeto; Nimesh D Desai; Douglas J Wiebe; Peter W Groeneveld; Matthew L Williams
Journal:  Am J Cardiol       Date:  2018-09-26       Impact factor: 2.778

7.  What influences the outcome of valve replacement in critical aortic stenosis?

Authors:  H Baumgartner
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

Review 8.  Pathophysiology of Aortic Valve Stenosis: Is It Both Fibrocalcific and Sex Specific?

Authors:  Yoginee Sritharen; Maurice Enriquez-Sarano; Hartzell V Schaff; Grace Casaclang-Verzosa; Jordan D Miller
Journal:  Physiology (Bethesda)       Date:  2017-05

9.  Long-term outcomes of isolated aortic valve replacement and concomitant AVR and coronary artery bypass grafting.

Authors:  G A de Waard; E K Jansen; M de Mulder; A B A Vonk; V A Umans
Journal:  Neth Heart J       Date:  2012-03       Impact factor: 2.380

Review 10.  Degenerative aortic stenosis.

Authors:  Radhakrishnan Ramaraj; Vincent L Sorrell
Journal:  BMJ       Date:  2008-03-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.